Understanding barriers to vaccination against invasive meningococcal disease: a survey of the knowledge gap and potential solutions

References

• Rappuoli R, Pizza M, Masignani V, et al. Meningococcal B vaccine (4CMenB): the journey from research to real world experience. Expert Rev Vaccines. 2018;17(12):1111–1121.DOI:10.1080/14760584.2018.1547637
   PubMed Web of Science ®Google Scholar
• Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2013;62(Rr–2):1–28.
   PubMed Web of Science ®Google Scholar
• Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016–2025. DOI:10.1056/NEJMoa1005384
   PubMed Web of Science ®Google Scholar
• Wang B, Santoreneos R, Giles L, et al. Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine. 2019;37(21):2768–2782. DOI:10.1016/j.vaccine.2019.04.020
   PubMed Web of Science ®Google Scholar
• Olbrich KJ, Muller D, Schumacher S, et al. Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers. Infect Dis Ther. 2018;7(4):421–438. DOI:10.1007/s40121-018-0213-2
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control (ECDC). Surveillance report: invasive meningococcal disease – annual epidemiological report for 2017. Available from: https://ecdc.europa.eu/en/publications-data/invasive-meningococcal-disease-annual-epidemiological-report-2017.
   Google Scholar
• Buysse CM, Raat H, Hazelzet JA, et al. Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge. Crit Care Med. 2008;36(2):596–602. DOI:10.1097/01.CCM.0000299740.65484.CA
   PubMed Web of Science ®Google Scholar
• Buysse CM, Oranje AP, Zuidema E, et al. Long-term skin scarring and orthopaedic sequelae in survivors of meningococcal septic shock. Arch Dis Child. 2009;94(5):381–386. DOI:10.1136/adc.2007.131862
   PubMed Web of Science ®Google Scholar
• Edmond K, Clark A, Korczak VS, et al. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(5):317–328. DOI:10.1016/S1473-3099(10)70048-7
   PubMed Web of Science ®Google Scholar
• World Health Organization. Intersectoral global action plan on epilepsy and other neurological disorders 2022-2031. Available from: https://cdn.who.int/media/docs/default-source/brain-health/first-draft-action-plan-on-epilepsy-and-other-neurological-disorders_180621_en.pdf?sfvrsn=16474e26_24&download=true.
   Google Scholar
• Shen J, Begum N, Ruiz-Garcia Y, et al. Range of invasive meningococcal disease sequelae and health economic application - a systematic and clinical review. BMC Public Health. 2022;22(1):1078. DOI:10.1186/s12889-022-13342-2
   PubMed Web of Science ®Google Scholar
• Rosenstein NE, Perkins BA, Stephens DS, et al. Meningococcal disease. N Engl J Med. 2001;344(18):1378–1388. DOI:10.1056/NEJM200105033441807
   PubMed Web of Science ®Google Scholar
• Peterson ME, Li Y, Bita A, et al. Meningococcal serogroups and surveillance: a systematic review and survey. J Glob Health. 2019;9(1):010409. DOI:10.7189/jogh.09.010409
   PubMed Web of Science ®Google Scholar
• Xie O, Pollard AJ, Mueller JE, et al. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine. Vaccine. 2013;31(27):2852–2861. DOI:10.1016/j.vaccine.2013.04.036
   PubMed Web of Science ®Google Scholar
• Pizza M, Bekkat-Berkani R, Rappuoli R. Vaccines against meningococcal diseases. Microorganisms. 2020;8(10):1521. DOI:10.3390/microorganisms8101521
   PubMed Web of Science ®Google Scholar
• Findlow J, Nuttens C, Kriz P. Introduction of a second MenB vaccine into Europe - needs and opportunities for public health. Expert Rev Vaccines. 2019;18(3):225–239.
   PubMed Web of Science ®Google Scholar
• Safadi MAP, Martinón-Torres F, Serra L, et al. Translating meningococcal serogroup B vaccines for healthcare professionals. Expert Rev Vaccines. 2021;20(4):401–414. DOI:10.1080/14760584.2021.1899820
   PubMed Web of Science ®Google Scholar
• Ruiz García Y, Sohn WY, Seib KL, et al. Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect. NPJ Vaccines. 2021;6(1):130. DOI:10.1038/s41541-021-00388-3
   PubMed Web of Science ®Google Scholar
• Mbaeyi SB, Duffy J, Duffy J, et al. Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020. (Ed.^(Eds). 2020;69(9):1–41. DOI:10.15585/mmwr.rr6909a1
   Google Scholar
• World Health Organization. Immunization coverage. Available from: https://www.who.int/news-room/fact-sheets/detail/immunization-coverage.
   Google Scholar
• Trotter CL, Lingani C, Fernandez K, et al. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data. Lancet Infect Dis. 2017;17(8):867–872. DOI:10.1016/S1473-3099(17)30301-8
   PubMed Web of Science ®Google Scholar
• Pingali C, Yankey D, Elam-Evans LD, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(35):1183–1190. DOI:10.15585/mmwr.mm7035a1
   PubMed Web of Science ®Google Scholar
• Wang B, Clarke M, Afzali HH, et al. Community, parental and adolescent awareness and knowledge of meningococcal disease. Vaccine. 2014;32(18): 2042–2049.
   Google Scholar
• Jackson C, Yarwood J, Saliba V, et al. UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis. BMJ Open. 2017;7(4):e012851. DOI:10.1136/bmjopen-2016-012851
   PubMed Web of Science ®Google Scholar
• Le Ngoc Tho S, Ader F, Ferry T, et al. Vaccination against serogroup B Neisseria meningitidis: perceptions and attitudes of parents. Vaccine. 2015;33(30):3463–3470. DOI:10.1016/j.vaccine.2015.05.073
   PubMed Web of Science ®Google Scholar
• Basta NE, Becker AB, Li Q, et al. Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens. Vaccine. 2019;37(4):670–676. DOI:10.1016/j.vaccine.2018.11.078
   PubMed Web of Science ®Google Scholar
• Drozd-Dabrowska M, Topczewska K, Korzen M, et al. Parental knowledge about meningococcal disease and vaccination uptake among 0-5 years old Polish children. Int J Environ Res Public Health. 2019;16(2):265. DOI:10.3390/ijerph16020265
   PubMed Web of Science ®Google Scholar
• Bakhache P, Rodrigo C, Davie S, et al. Health care providers’ and parents’ attitudes toward administration of new infant vaccines–a multinational survey. Eur J Pediatr. 2013;172(4):485–492. DOI:10.1007/s00431-012-1904-4
   PubMed Web of Science ®Google Scholar
• Marshall H, Ryan P, Roberton D, et al. A cross-sectional survey to assess community attitudes to introduction of human papillomavirus vaccine. Aust N Z J Public Health. 2007;31(3):235–242. DOI:10.1111/j.1467-842X.2007.00054.x
   PubMed Web of Science ®Google Scholar
• Coyne-Beasley T, Reiter PL, Liberty AC, et al. Awareness is not enough: the need to increase meningococcal vaccine uptake. Clin Pediatr (Phila). 2013;52(5):441–450. DOI:10.1177/0009922813481847
   PubMed Web of Science ®Google Scholar
• World Health Organization. Defeating meningitis by 2030; 2021. Available from: https://www.who.int/publications/i/item/9789240026407
   Google Scholar
• Morrone T, Napolitano F, Albano L, et al. Meningococcal serogroup B vaccine: knowledge and acceptability among parents in Italy. Hum Vaccin Immunother. 2017;13(8):1921–1927. DOI:10.1080/21645515.2017.1313940
   PubMed Web of Science ®Google Scholar
• Pelullo CP, Napolitano F, Di Giuseppe G. Meningococcal disease and vaccination: knowledge and acceptability among adolescents in Italy. Hum Vaccin Immunother. 2018;14(5):1197–1202. DOI:10.1080/21645515.2018.1436918
   PubMed Web of Science ®Google Scholar
• Timmermans DR, Henneman L, Hirasing RA, et al. Attitudes and risk perception of parents of different ethnic backgrounds regarding meningococcal C vaccination. Vaccine. 2005;23(25):3329–3335. DOI:10.1016/j.vaccine.2005.01.075
   PubMed Web of Science ®Google Scholar
• Richardson E, Ryan KA, Lawrence RM, et al. Perceptions and knowledge about the MenB vaccine among parents of high school students. J Community Health. 2021;46(4):808–816. DOI:10.1007/s10900-020-00954-1
   PubMed Web of Science ®Google Scholar
• Martinón-Torres F, Taha MK, Knuf M, et al. Evolving strategies for meningococcal vaccination in Europe: overview and key determinants for current and future considerations. Pathog Glob Health. 2022;116(2):85–98. DOI:10.1080/20477724.2021.1972663
   PubMed Web of Science ®Google Scholar
• Aparecido Nunes A, De Jesus Lopes De Abreu A, Cintra O, et al. Meningococcal disease epidemiology in Brazil (2005-2018) and impact of MenC vaccination. Vaccine. 2021;39(3):605–616. DOI:10.1016/j.vaccine.2020.11.067
   PubMed Web of Science ®Google Scholar
• Guzman-Holst A, DeAntonio R, Prado-Cohrs D, et al. Barriers to vaccination in Latin America: a systematic literature review. Vaccine. 2020;38(3):470–481. DOI:10.1016/j.vaccine.2019.10.088
   PubMed Web of Science ®Google Scholar
• van Lier A, Ferreira JA, Mollema L, et al. Intention to vaccinate universally against varicella, rotavirus gastroenteritis, meningococcal B disease and seasonal influenza among parents in the Netherlands: an internet survey. BMC Res Notes. 2017;10(1):672. DOI:10.1186/s13104-017-3004-z
   PubMedGoogle Scholar
• Dube E, Gagnon D, Hamel D, et al. Parents’ and adolescents’ willingness to be vaccinated against serogroup B meningococcal disease during a mass vaccination in saguenay-lac-st-jean (Quebec). Can J Infect Dis Med Microbiol. 2015;26(3):163–167. DOI:10.1155/2015/732464
   PubMed Web of Science ®Google Scholar
• Dorell C, Yankey D, Strasser S. Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, national immunization survey: teen, 2009. Clin Pediatr (Phila). 2011;50(12):1116–1124.
   PubMed Web of Science ®Google Scholar
• Reiter PL, Gilkey MB, Brewer NT. HPV vaccination among adolescent males: results from the national immunization survey-teen. Vaccine. 2013;31(26):2816–2821.
   PubMed Web of Science ®Google Scholar
• Stokley S, Cohn A, Dorell C, et al. Adolescent vaccination-coverage levels in the United States: 2006-2009. Pediatrics. 2011;128(6):1078–1086. DOI:10.1542/peds.2011-1048
   PubMed Web of Science ®Google Scholar
• Sonawane K, Zhu Y, Montealegre JR, et al. Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey. Lancet Public Health. 2020;5(9):e484–492. DOI:10.1016/S2468-2667(20)30139-0
   PubMed Web of Science ®Google Scholar
• Lindley MC, Jeyarajah J, Yankey D, et al. Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls. Hum Vaccin Immunother. 2016;12(6):1519–1527. DOI:10.1080/21645515.2016.1157673
   PubMed Web of Science ®Google Scholar
• Dorell C, Yankey D, Kennedy A, et al. Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: national immunization survey-teen, 2010. Clin Pediatr (Phila). 2013;52(2):162–170. DOI:10.1177/0009922812468208
   PubMed Web of Science ®Google Scholar
• Perkins RB, Lin M, Silliman RA, et al. Why are U.S. girls getting meningococcal but not human papilloma virus vaccines? Comparison of factors associated with human papilloma virus and meningococcal vaccination among adolescent girls 2008 to 2012. Womens Health Issues. 2015;25(2):97–104. DOI:10.1016/j.whi.2014.12.005
   PubMed Web of Science ®Google Scholar
• Rahman M, Laz TH, McGrath CJ, et al. Provider recommendation mediates the relationship between parental human papillomavirus (HPV) vaccine awareness and HPV vaccine initiation and completion among 13- to 17-year-old U.S. adolescent children. Clin Pediatr (Phila). 2015;54(4):371–375. DOI:10.1177/0009922814551135
   PubMed Web of Science ®Google Scholar
• Reiter PL, McRee AL, Pepper JK, et al. Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. Am J Public Health. 2013;103(8):1419–1427. DOI:10.2105/AJPH.2012.301189
   PubMed Web of Science ®Google Scholar
• Ylitalo KR, Lee H, Mehta NK. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US national immunization survey. Am J Public Health. 2013;103(1):164–169.
   PubMed Web of Science ®Google Scholar
• Bernstein HH, Bocchini JA Jr, Byington CL. Committee on infectious diseases. The need to optimize adolescent immunization. Pediatrics. 2017;139(3):e20164186.
   PubMedGoogle Scholar
• Griffin DS, Muhlbauer G, Griffin DO. Adolescents trust physicians for vaccine information more than their parents or religious leaders. Heliyon. 2018;4(12):e01006.
   PubMed Web of Science ®Google Scholar
• Gaudelus J, Cohen R, Leboucher B, et al. Meningococcal C vaccine coverage in France in infants, children, and adolescents. Med Mal Infect. 2019;49(3):180–186. DOI:10.1016/j.medmal.2019.01.014
   PubMed Web of Science ®Google Scholar
• Marshall HS, Chen G, Clarke M, et al. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: a discrete choice experiment. Vaccine. 2016;34(5):671–677. DOI:10.1016/j.vaccine.2015.11.075
   PubMed Web of Science ®Google Scholar
• Lavelle TA, Messonnier M, Stokley S, et al. Use of a choice survey to identify adult, adolescent and parent preferences for vaccination in the United States. J Patient Rep Outcomes. 2019;3(1):51. DOI:10.1186/s41687-019-0135-0
   PubMedGoogle Scholar
• Vu M, King AR, Jang HM, et al. Practice-, provider- and patient-level facilitators of and barriers to HPV vaccine promotion and uptake in Georgia: a qualitative study of healthcare providers’ perspectives. Health Educ Res. 2020;35(6):512–523. DOI:10.1093/her/cyaa026
   PubMed Web of Science ®Google Scholar
• Bedford H, Attwell K, Danchin M, et al. Vaccine hesitancy, refusal and access barriers: the need for clarity in terminology. Vaccine. 2018;36(44):6556–6558. DOI:10.1016/j.vaccine.2017.08.004
   PubMed Web of Science ®Google Scholar
• Roberts JR, Thompson D, Rogacki B, et al. Vaccine hesitancy among parents of adolescents and its association with vaccine uptake. Vaccine. 2015;33(14):1748–1755. DOI:10.1016/j.vaccine.2015.01.068
   PubMed Web of Science ®Google Scholar
• Strelitz B, Gritton J, Klein EJ, et al. Parental vaccine hesitancy and acceptance of seasonal influenza vaccine in the pediatric emergency department. Vaccine. 2015;33(15):1802–1807. DOI:10.1016/j.vaccine.2015.02.034
   PubMed Web of Science ®Google Scholar
• Williams SE. What are the factors that contribute to parental vaccine-hesitancy and what can we do about it? Hum Vaccin Immunother. 2014;10(9):2584–2596.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Ten Threats to global health in 2019. Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019
   Google Scholar
• Badur S, Ota M, Ozturk S, et al. Vaccine confidence: the keys to restoring trust. Hum Vaccin Immunother. 2020;16(5):1007–1017. DOI:10.1080/21645515.2020.1740559
   PubMed Web of Science ®Google Scholar
• Ponticelli D, D’Ambrosio A, Cancellieri M, et al. Do HCWs adequately know about meningitis and 4CMenB vaccine and recommend its use to parents? A cross sectional analysis in Campania region, Italy. J Prev Med Hyg. 2019;60(2):E147–157. DOI:10.15167/2421-4248/jpmh2019.60.2.1018
   PubMedGoogle Scholar
• Ferrara P, Stromillo L, Albano L. Awareness, attitudes, and practices toward meningococcal B vaccine among pediatricians in Italy. Med (Kaunas). 2018;54(6):100.
   PubMed Web of Science ®Google Scholar
• Kempe A, Allison MA, MacNeil JR, et al. Adoption of serogroup B meningococcal vaccine recommendations. Pediatrics. 2018;142(3):e20180344. DOI:10.1542/peds.2018-0344
   PubMed Web of Science ®Google Scholar
• Wagner A, Kundi M, Zwiauer K, et al. Paediatricians require more information before they routinely co-administer the meningococcal B vaccine with routine infant vaccines. Acta Paediatr. 2015;104(10):e439–447. DOI:10.1111/apa.13100
   PubMed Web of Science ®Google Scholar
• Masaquel C, Schley K, Wright K, et al. The impact of social determinants of health on meningococcal vaccination awareness, delivery, and coverage in adolescents and young adults in the United States: a systematic review. Vaccines (Basel). 2023;11(2):256. DOI:10.3390/vaccines11020256
   PubMed Web of Science ®Google Scholar
• Middleton BF, Davies J, Webby R. Vaccine success and challenges in northern Australia. Microbiol Aust. 2022;43(3):113–116.
   Web of Science ®Google Scholar
• Brewer NT, Hall ME, Malo TL, et al. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139(1):e20161764. DOI:10.1542/peds.2016-1764
   PubMed Web of Science ®Google Scholar
• Kaufman J, Ryan R, Walsh L, et al. Face-to-face interventions for informing or educating parents about early childhood vaccination. Cochrane Database Syst Rev. 2018;5(5):Cd010038. DOI:10.1002/14651858.CD010038.pub3
   PubMed Web of Science ®Google Scholar
• Cox AD, Cox D, Cyrier R, et al. Can self-prediction overcome barriers to hepatitis B vaccination? A randomized controlled trial. Health Psychol. 2012;31(1):97–105. DOI:10.1037/a0025298
   PubMed Web of Science ®Google Scholar
• Smedley J, Poole J, Waclawski E, et al. Influenza immunisation: attitudes and beliefs of UK healthcare workers. Occup Environ Med. 2007;64(4):223–227. DOI:10.1136/oem.2005.023564
   PubMed Web of Science ®Google Scholar
• Brown K, Fraser G, Ramsay M, et al. Attitudinal and demographic predictors of measles-mumps-rubella vaccine (MMR) uptake during the UK catch-up campaign 2008-09: cross-sectional survey. PLoS ONE. 2011;6(5):e19381. DOI:10.1371/journal.pone.0019381
   PubMed Web of Science ®Google Scholar
• Bekkat-Berkani R, Romano-Mazzotti L. Understanding the unique characteristics of seasonal influenza illness to improve vaccine uptake in the US. Vaccine. 2018;36(48):7276–7285.
   PubMed Web of Science ®Google Scholar
• Jacobson RM, St Sauver JL, Griffin JM, et al. How health care providers should address vaccine hesitancy in the clinical setting: evidence for presumptive language in making a strong recommendation. Hum Vaccin Immunother. 2020;16(9):2131–2135. DOI:10.1080/21645515.2020.1735226
   PubMed Web of Science ®Google Scholar
• Gagneur A. Motivational interviewing: a powerful tool to address vaccine hesitancy. Can Commun Dis Rep. 2020;46(4):93–97.
   PubMedGoogle Scholar
• Gagneur A, Lemaitre T, Gosselin V, et al. A postpartum vaccination promotion intervention using motivational interviewing techniques improves short-term vaccine coverage: PromoVac study. BMC Public Health. 2018;18(1):811. DOI:10.1186/s12889-018-5724-y
   PubMedGoogle Scholar
• Taha MK, Martinon-Torres F, Köllges R, et al. Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease. Expert Rev Vaccines. 2022;21(5):659–674. DOI:10.1080/14760584.2022.2052048
   PubMed Web of Science ®Google Scholar
• Harris SK, Aalsma MC, Weitzman ER, et al. Research on clinical preventive services for adolescents and young adults: where are we and where do we need to go? J Adolesc Health. 2017;60(3):249–260. DOI:10.1016/j.jadohealth.2016.10.005
   PubMed Web of Science ®Google Scholar
• Hofstetter AM, Vargas CY, Kennedy A, et al. Parental and provider preferences and concerns regarding text message reminder/recall for early childhood vaccinations. Prev Med. 2013;57(2):75–80. DOI:10.1016/j.ypmed.2013.04.007
   PubMed Web of Science ®Google Scholar
• GSK. Meningitis bewegt. Available from: https://www.meningitis-bewegt.de/
   Google Scholar
• ClinicalTrials.gov. NCT04502693. Study to assess effectiveness of GlaxoSmithKline’s (Gsk’s) meningococcal group B and combined ABCWY vaccines in healthy adolescents and young adults. Available from: https://clinicaltrials.gov/ct2/show/NCT04502693
   Google Scholar
• Borrow R, Alarcón P, Carlos J, et al. The global Meningococcal initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. Expert Rev Vaccines. 2017;16(4):313–328. DOI:10.1080/14760584.2017.1258308
   PubMed Web of Science ®Google Scholar
• Meningitis research foundation. About us. About us: https://www.meningitis.org/about-us
   Google Scholar
• Confederation of meningitis organisations. About us. About us: http://www.comomeningitis.org/about-us/
   Google Scholar
• Meningitis research foundation. One life, one shot. Available from: https://www.meningitis.org/our-work/advocacy-and-campaigning/one-life-one-shot.
   Google Scholar
• Meningitis research foundation. Report highlights meningitis being missed. Available from: https://www.meningitis.org/news/safety-netting
   Google Scholar
• Meningitis now. Beat it now! campaign timeline. Available from: https://www.meningitisnow.org/support-us/news-centre/public-affairs/campaigns/beat-it-now/campaign-timeline/
   Google Scholar
• Meningitis research foundation. Where’s our vaccine?. Available from: https://www.meningitis.org/our-work/advocacy-and-campaigning/wheres-our-vaccine
   Google Scholar
• Meningitis Research Foundation. Counting the costs. Available from: https://www.meningitis.org/our-work/completed-projects/counting-the-costs
   Google Scholar
• Borrow R, Caugant DA, Ceyhan M, et al. Meningococcal disease in the middle east and Africa: findings and updates from the global Meningococcal initiative. J Infect. 2017;75(1):1–11. DOI:10.1016/j.jinf.2017.04.007
   PubMed Web of Science ®Google Scholar
• Sohn WY, Tahrat H, Novy P, et al. Real-world implementation of 4-component meningococcal serogroup B vaccine (4CMenB): implications for clinical practices. Expert Rev Vaccines. 2022;21(3):325–335. DOI:10.1080/14760584.2022.2021881
   PubMed Web of Science ®Google Scholar
• Carr J, Plested E, Aley P, et al. “Be on the TEAM“ study (teenagers against meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents. BMJ Open. 2020;10(10):e037358. DOI:10.1136/bmjopen-2020-037358
   PubMed Web of Science ®Google Scholar
• Ladhani SN, Andrews N, Parikh SR, et al. Vaccination of infants with meningococcal group B vaccine (4CMenB) in England. N Engl J Med. 2020;382(4):309–317. DOI:10.1056/NEJMoa1901229
   PubMed Web of Science ®Google Scholar
• UK Health Security Agency. Impact of COVID-19 on childhood vaccination counts up to week 6; 2021. Available from: https://www.gov.uk/government/publications/covid-19-impact-on-vaccination-programmes/impact-of-covid-19-on-childhood-vaccination-counts-up-to-week-6-2021
   Google Scholar
• Snyder Bulik B. GSK’s message to college-bound kids and their parents: get meningitis B vaccine; 2018. Available from: https://www.fiercepharma.com/marketing/gsk-push-to-college-bound-kids-and-their-parents-get-men-b-vaccinated
   Google Scholar
• Blagden S, Seddon D, Hungerford D, et al. Uptake of a new meningitis vaccination programme amongst first-year undergraduate students in the United Kingdom: a cross-sectional study. PLoS ONE. 2017;12(8):e0181817. DOI:10.1371/journal.pone.0181817
   PubMed Web of Science ®Google Scholar
• Wilson SL, Wiysonge C. Social media and vaccine hesitancy. BMJ Glob Health. 2020;5(10):e004206.
   PubMed Web of Science ®Google Scholar
• Bíró A, Szabó-Morvai Á. Mass media coverage and vaccination uptake: evidence from the demand for meningococcal vaccinations in Hungary. Eur J Health Econ. 2021;22(6):887–903.
   PubMed Web of Science ®Google Scholar